/* ************************* */ /* per gallery responsive */ /* ************************* */
Salta al contenuto principaleStanford Medicine researchers have shown that prior SARS-CoV-2 infection reduces killer T cells’ response to vaccination. These cells are crucial for eliminating the virus from the body. The Pfizer/BioNTech mRNA vaccine directed at COVID-19 is much better than natural infection at revving up key immune cells called killer T cells to fight future infection by SARS-CoV-2, the virus that causes COVID-19, Stanford Medicine investigators have found....
Leggi il testo integrale dell'articolo in lingua inglese su The Harvard Gazette
0 Commenti.